COLUMBUS (COLUMBUS BUSINESS FIRST) — A Nationwide Children’s Hospital affiliate could start construction in October on a $74 million biotechnology manufacturing facility for genetic material used in research and clinical trials, according to materials related to a proposed economic incentive.
Andelyn Biosciences Inc. also appears closer to selecting a
site: a project map in Columbus City Council documents shows an 8-acre parcel
carved out of Ohio State University west campus at the southwest corner of Lane
Avenue and Carmack Road. Both OSU and the hospital say the site is proposed but
not yet final.
Children’s created Andelyn, a for-profit affiliate, to at first
take over in-house genetic material production inside the hospital’s Wexner
Research Institute. It plans to build a 85,000-square-foot facility, with many
multiples of the current capacity, targeted for a 2023 opening.